DAVID J CANCIAN

Allopathic & Osteopathic Physicians|Internal Medicine WATERTOWN, MA NPI 1962496539

General Payments — all program years on this page

$7,643.93

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 423
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $406.62 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $374.3515
Education $32.271

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,957.27112
2019 $2,050.49123
2020 $406.0922
2021 $485.3126
2022 $1,077.5460
2023 $1,260.6164
2024 $406.6216

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096942325 Novo Nordisk Inc $20.51 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097265360 Novo Nordisk Inc $21.55 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097816877 Novo Nordisk Inc $32.27 10/15/2024 Education Undisputed 01/23/2026 View at CMS
1104205645 AstraZeneca Pharmaceuticals LP $34.22 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104238937 AstraZeneca Pharmaceuticals LP $22.56 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104381779 AstraZeneca Pharmaceuticals LP $25.77 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104416469 AstraZeneca Pharmaceuticals LP $27.06 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105866064 AstraZeneca Pharmaceuticals LP $23.72 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111542143 Amgen Inc. $28.11 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114606565 Exact Sciences Corporation $21.32 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116535698 GlaxoSmithKline, LLC. $22.06 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116730740 GlaxoSmithKline, LLC. $26.39 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118252692 Boehringer Ingelheim Pharmaceuticals, Inc. $22.09 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118252694 Boehringer Ingelheim Pharmaceuticals, Inc. $32.12 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136139877 Lilly USA, LLC $23.52 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141727988 Merck Sharp & Dohme LLC $23.35 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.